雲南白藥(000538.SZ)與中金公司簽署場外衍生品交易相關協議
格隆匯5月19日丨雲南白藥(000538.SZ)公佈,近日,公司與中國國際金融股份有限公司(“中金公司”)陸續簽署了《衍生品交易方案設計服務協議》、《中國證券期貨市場衍生品交易主協議》、《中國證券期貨市場衍生品交易主協議補充協議》、《場外衍生品交易履約保障協議》,後續將視回購進展情況不時簽署其他相關協議。
公司採取的回購模式為:雙方在法律框架內簽署場外衍生品系列協議,由中金公司按照內部模型進行自主對衝交易,以使得雲南白藥用場外衍生品交易中的損益(如有)控制實際回購股票的成本。
雲南白藥與中金公司作為戰略合作伙伴,此次回購按照“專業人幹專業事”的原則,綜合借鑑國際經驗並結合國內監管要求,在依法合規前提下與中金公司進行場外衍生品交易,以支持公司順利實施股份回購並控制回購成本,符合公司的利益訴求及戰略發展需要,能夠為公司建立常態化的員工激勵機制提供支撐,保障全體股東的合法權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.